Australian Healthcare Herald
SEE OTHER BRANDS

Catch up with healthcare and wellness news from Australia

Australian Healthcare Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Australian Healthcare Herald.

Press releases published on June 11, 2025

Vietnam’s Vinmec Healthcare System Performs Its First Total Femoral Replacement  for World’s Youngest Cancer Patient

Vietnam’s Vinmec Healthcare System Performs Its First Total Femoral Replacement for World’s Youngest Cancer Patient

HANOI, VIETNAM, June 11, 2025 /⁨EINPresswire.com⁩/ -- Vinmec Healthcare System has successfully performed a Total Femoral Replacement (TFR) surgery using personalized 3D printing materials for the world's youngest cancer patient. It is also the first …

Savista Launches Yoga & Wellness Retreat,  Combined with Village Experience & Cultural Immersion

Savista Launches Yoga & Wellness Retreat, Combined with Village Experience & Cultural Immersion

Discover healing in the heart of Rajasthan with immersive yoga, Ayurvedic advice, and authentic village life, at Savista Retreat. JAIPUR, RAJASTHAN, INDIA, June 11, 2025 /⁨EINPresswire.com⁩/ -- Savista Retreat, an eco-conscious boutique property nestled …

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases

SYDNEY, June 11, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, …

Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.

Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.

MELBOURNE, Australia and INDIANAPOLIS, June 11, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that its next-generation PSMA-PET imaging1 agent for prostate cancer, Gozellix® (kit for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service